Showing results (131-140 of 162) with videos related to
Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Bromodeoxyuridine alternating with radiation for advanced uterine cervix cancer: a phase I and drug incorporation studyA Eisbruch, J M Robertson, C M Johnston, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2000
Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignanciesL A Dawson, C J McGinn, D Normolle, et al.International Journal of Radiation Oncology, Biology, Physics|March 1, 1988
Retrospective analysis of stage I and II indolent lymphomas at the National Cancer InstituteT S Lawrence, W J Urba, S M Steinberg, et al.International Journal of Radiation Oncology, Biology, Physics|October 15, 1994
Bromodeoxyuridine-mediated radiosensitization in human glioma: the effect of concentration, duration, and fluoropyrimidine modulationP W McLaughlin, T S Lawrence, H Seabury, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 1, 1991
Technical considerations in the use of 3-D beam arrangements in the abdomenR K Ten Haken, T S Lawrence, D L McShan, et al.Cancer Research|December 16, 2000
Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenograftsE Kievit, M K Nyati, E Ng, et al.Cancer Research|August 1, 1991
Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivoT S Lawrence, M A Davis, P E McKeever, et al.International Journal of Radiation Oncology, Biology, Physics|December 10, 1997
A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastasesJ M Robertson, C J McGinn, S Walker, et al.Gene Therapy|June 25, 2002
The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer modelM K Nyati, Z Symon, E Kievit, et al.Proceedings of the National Academy of Sciences of the United States of America|August 18, 1999
Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopyL D Stegman, A Rehemtulla, B Beattie, et al.Pageof 17